v3 Template
A

Axon Therapies

Medical Technology / Healthcare ~400 employees
Founded
--
Employees (Est.)
~400
20 leaders known
Total Funding
$32.0M
Funding Rounds
1
Last Funding
2025-09-25

About Axon Therapies

Axon Therapies is a medical technology company focused on rebalancing heart failure through innovative solutions. Their mission is to address the root causes of heart failure, particularly in patients with preserved ejection fraction (HFpEF), by calming sympathetic nerve activity and normalizing volume balance using their SAVM (Splanchnic Ablation for Volume Management) procedure.

Products & Services

SAVM (Splanchnic Ablation for Volume Management):A minimally invasive, implant-free procedure using the Satera Ablation System to ablate the Greater Splanchnic Nerve, aiming to normalize volume balance, increase cardiac functional capacity, and improve symptoms for heart failure patients with preserved ejection fraction (HFpEF).
Satera Ablation System:An investigational device used in the SAVM procedure to perform targeted ablation therapy via the femoral vein to block nerve signals near the right greater splanchnic nerve.

Specialties

Heart Failure Treatment Splanchnic Ablation Volume Management Sympathetic Nerve Activity Modulation HFpEF (Heart Failure with Preserved Ejection Fraction) Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 32000000
MR: -
FA: $32 million
FAN: 32000000 		D: 2025-09-25
FD: 2025-09-25 		5 investors
Series A Latest
2025-09-25
$32.0M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

Z

Zoar Engelman

President & CEO

LinkedIn (Pro only)
P

PJ Iranitalab

SVP of Engineering & Operations

LinkedIn (Pro only)
M

Matthew Stark

SVP of Clinical & Regulatory Affairs

LinkedIn (Pro only)
H

Howard Levin

CMO

S

Sanjiv Shah

Stone Endowed Professor of Medicine and Director of Research for the Bluhm Cardiovascular Institute at Northwestern University Feinberg School of Medicine

P

Piotr Ponikowski

Professor of Medical Sciences and Cardiologist

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

Axon Therapies Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Medical Technology / Healthcare
Company Size
~400 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro